Skip to main content

Table 1 Baseline characteristics of children receiving first-line NNRTI-based HAART

From: Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Characteristics*

N

 

Age, years

107

6.2(4.2-8.9)

Female,%

107

52.3

CDC clinical classification N:A:B:C,%

107

4:44:30:22

Weight for age z-score

107

-1.5(-2.4 to -0.4)

Height for age z-score

107

-1.7(-2.6 to -1.1)

Weight for height z-score

107

-0.5(-1.6 to 0.3)

Hemoglobin, g/dL

78

10.6(9.5-11.7)

CD4%

101

7(3-15)

CD4 count, cells/mm3

101

151(35-477)

HIV-RNA log10 copies/ml

100

5(4.9-5.5)

NVP:EFV-based HAART,%

107

70:30

  1. CDC: Center for Disease Control and Prevention, NVP: nevirapine, EFV: efavirenz,
  2. HAART: highly active antiretroviral therapy
  3. *Data was shown in median (IQR) or percentage